{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-24-000794","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.936707+00:00","generated_at":"2026-06-05T04:45:35.374818+00:00","sec_items":["7.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Entera Bio regains Nasdaq minimum bid price compliance, delisting risk removed","bullets":["Received Nasdaq notice on March 1, 2024 confirming bid price compliance.","Ordinary shares closed at $1.00+ for 10 consecutive business days to satisfy rule.","Listing matter is now closed; no further action required.","Press release issued March 4, 2024 announcing the compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-24-000794","json":"https://secwatch.observer/filing/0001178913-24-000794.json","markdown":"https://secwatch.observer/filing/0001178913-24-000794.md","text":"https://secwatch.observer/filing/0001178913-24-000794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324000794/0001178913-24-000794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891324000794/zk2431079.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:45:35.374818+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}